Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,738 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Asymptomatic glomerulonephritis].
Osawa G, Hashimoto J, Hirano H, Okamoto M, Shindo T, Yoneda M, Matsutani T. Osawa G, et al. Among authors: yoneda m. Nihon Rinsho. 1984 Jun;42(6):1334-8. Nihon Rinsho. 1984. PMID: 6481996 Japanese. No abstract available.
Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction-associated steatotic liver disease.
Ishiba H, Fujii H, Kamada Y, Sumida Y, Takahashi H, Seko Y, Toyoda H, Hayashi H, Yamaguchi K, Iwaki M, Yoneda M, Arai T, Shima T, Morishita A, Kawata K, Tomita K, Kawanaka M, Yoshida Y, Ikegami T, Notsumata K, Oeda S, Fukushima H, Miyoshi E, Aishima S, Itoh Y, Okanoue T, Nakajima A; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Ishiba H, et al. Among authors: yoneda m. Hepatol Commun. 2024 Dec 11;9(1):e0563. doi: 10.1097/HC9.0000000000000563. eCollection 2025 Jan 1. Hepatol Commun. 2024. PMID: 39670882 Free PMC article.
Head-to-head comparison among FAST, MAST, and multiparametric MRI-based new score in diagnosing at-risk MASH.
Imajo K, Saigusa Y, Kobayashi T, Nagai K, Nishida S, Kawamura N, Doi H, Iwaki M, Nogami A, Honda Y, Kessoku T, Ogawa Y, Kirikoshi H, Kokubu S, Utsunomiya D, Takahashi H, Aishima S, Sumida Y, Saito S, Yoneda M, Dennis A, Kin S, Andersson A, Nakajima A. Imajo K, et al. Among authors: yoneda m. Eur Radiol. 2024 Dec 5. doi: 10.1007/s00330-024-11215-3. Online ahead of print. Eur Radiol. 2024. PMID: 39638942
Pemafibrate for treating MASLD complicated by hypertriglyceridaemia: a multicentre, open-label, randomised controlled trial study protocol.
Iwaki M, Kobayashi T, Nogami A, Ogawa Y, Imajo K, Sakai E, Nakada Y, Koyama S, Kurihashi T, Oza N, Kohira T, Okada M, Yamaguchi Y, Iwane S, Kageyama F, Sasada Y, Matsushita M, Tadauchi A, Murohisa G, Nagasawa M, Sato S, Maeda K, Furuta K, Shigefuku R, Seko Y, Tobita H, Kawata K, Kawanaka M, Sugihara T, Tamaki N, Iwasa M, Kawaguchi T, Itoh Y, Kawaguchi A, Takahashi H, Nakajima A, Yoneda M. Iwaki M, et al. Among authors: yoneda m. BMJ Open. 2024 Nov 24;14(11):e088862. doi: 10.1136/bmjopen-2024-088862. BMJ Open. 2024. PMID: 39581726 Free PMC article. Clinical Trial.
Serum Cytokeratin 18 Fragment Is an Indicator for Treating Metabolic Dysfunction-Associated Steatotic Liver Disease.
Kawanaka M, Kamada Y, Takahashi H, Iwaki M, Nishino K, Zhao W, Seko Y, Yoneda M, Kubotsu Y, Fujii H, Sumida Y, Kawamoto H, Itoh Y, Nakajima A; Japan Study Group of NAFLD (JSG-NAFLD). Kawanaka M, et al. Among authors: yoneda m. Gastro Hep Adv. 2024 Aug 14;3(8):1120-1128. doi: 10.1016/j.gastha.2024.08.008. eCollection 2024. Gastro Hep Adv. 2024. PMID: 39533978 Free PMC article.
Effects of ipragliflozin on skeletal muscle adiposity in patients with diabetes and metabolic dysfunction-associated steatotic liver disease.
Ishimaru Y, Kessoku T, Nonaka M, Kitajima Y, Hyogo H, Nakajima T, Imajo K, Kubotsu Y, Isoda H, Kawanaka M, Yoneda M, Anzai K, Nakajima A, Furukawa K, Kawaguchi A, Takahashi H. Ishimaru Y, et al. Among authors: yoneda m. Intern Med. 2024 Nov 1. doi: 10.2169/internalmedicine.4456-24. Online ahead of print. Intern Med. 2024. PMID: 39496446 Free article.
1,738 results